HIV/AIDS Therapeutic and Non-vaccine Prevention Clinical Research

HIV/艾滋病治疗和非疫苗预防临床研究

• 批准号: 8556616
• 金额: $ 160.51万
• 依托单位: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/8556616
• 关键词: Acquired Immunodeficiency Syndrome; Africa; Agreement; Clinical Research; Couples; HIV; Infection; Military Personnel; Modality; Prevention; Prevention strategy; Preventive Intervention; Prophylactic treatment; Sexually Transmitted Diseases; Therapeutic; Vaccines; Vertical Disease Transmission; clinical research site; microbicide; novel; programs

The purpose of this Interagency Agreement is to define and authorize implementation of a collaborative human immunodeficiency/virus/acquired immune deficiency syndrome (HIV/AIDS) Therapeutic and Non-vaccine Prevention Clinical Research Program aimed at evaluating HIV/AIDS therapeutic and non-vaccine prevention interventions, especially in the developing world where US military troops may be deployed. The agreement will allow the continuation of HIV/AIDS clinical research at two clinical research sites (CRS) in Africa.

这一机构一致的目的是定义和授权实施人类免疫缺陷/获得的免疫缺陷综合症（HIV/AIDS）治疗和非疫苗预防临床研究计划，旨在评估HIV/AIDS治疗和非疫苗预防措施，尤其是在整个部队中，都可以评估治疗和非疫苗预防干预措施。该协议将允许在非洲两个临床研究地点（CRS）继续进行艾滋病毒/艾滋病临床研究。